560 F.3d 1331 (Fed. Cir. 2009), 2008-1453, In re Gleave

This document cites

• Federal Cases - 127 F.2d 149 (Fed. Cir. 1942), 4566, In re Von Bramer
• Federal Cases - 301 F.2d 929 (Fed. Cir. 1962), 6727, In re Application of LeGrice
• Federal Cases - 329 F.2d 1006 (Fed. Cir. 1964), 7193, In re Application of Brown
• Federal Cases - 410 F.2d 1403 (Fed. Cir. 1969), 8126, In re Application of Hafner
• Federal Cases - 488 F.2d 538 (Fed. Cir. 1973), 8806, In re Application of Wiggins



See all quotations

• Federal Cases - 571 F.2d 559 (Fed. Cir. 1978), 77-585, Application of Samour
• Federal Cases - 766 F.2d 531 (Fed. Cir. 1985), 85-868, In re Donohue
• Federal Cases - 910 F.2d 831 (Fed. Cir. 1990), 90-1023, In re Bond
• Federal Cases - 911 F.2d 705 (Fed. Cir. 1990), 90-1109, In re Spada
• Federal Cases - 935 F.2d 1555 (Fed. Cir. 1991), 90-1528, Vas-Cath Inc. v. Mahurkar
• Federal Cases - 964 F.2d 1122 (Fed. Cir. 1992), 91-1421, In re Schoenwald
• Federal Cases - 188 F.3d 1362 (Fed. Cir. 1999), 98-1438, Enzo Biochem v Calgene
• Federal Cases - 203 F.3d 1305 (Fed. Cir. 2000), 99-1241, In re In re Robert J. Gartside
• Federal Cases - 246 F.3d 1368 (Fed. Cir. 2001), 00-1304, Bristol-Meyers Squibb Co. v. Ben Venue Laboratories Inc.
• Federal Cases - 303 F.3d 1294 (Fed. Cir. 2002), 00-1429, Minnesota Min. & Mfg. Co. v. Chemque, Inc.
• Federal Cases - 339 F.3d 1373 (Fed. Cir. 2003), 02-1540, Schering Corp. v. Geneva Pharmaceuticals
• Federal Cases - 381 F.3d 1125 (Fed. Cir. 2004), 03-1569, In re Elsner
• Federal Cases - 413 F.3d 1318 (Fed. Cir. 2005), 04-1191, Rasmusson v. SmithKline Beecham Corp.
• Federal Cases - 424 F.3d 1347 (Fed. Cir. 2005), 04-1581, Novo Nordisk Pharmaceuticals, Inc. v. Bio-Technology General Corp.
• Federal Cases - 432 F.3d 1368 (Fed. Cir. 2005), 05-1022, Perricone v. Medicis Pharmaceutical Corp.
• Federal Cases - 441 F.3d 991 (Fed. Cir. 2006), 05-1359, Atofina v. Great Lakes Chemical Corp.
• Federal Cases - 468 F.3d 1366 (Fed. Cir. 2006), 05-1313, Impax Laboratories, Inc. v. Aventis Pharmaceuticals Inc.
• Federal Cases - 471 F.3d 1369 (Fed. Cir. 2006), 05-1396, Eli Lilly and Co. v. Zenith Goldline Pharmaceuticals, Inc.
• Federal Cases - 545 F.3d 1312 (Fed. Cir. 2008), 2007-1513, Impax Laboratories, Inc. v. Aventis Pharmaceuticals, Inc.
• Federal Cases - 545 F.3d 1359 (Fed. Cir. 2008), 2007-1565, Net MoneyIN, Inc. v. VeriSign, Inc.
• US Code - 35 U.S.C. § 102 Conditions For Patentability; Novelty
• US Code - 35 U.S.C. § 112 Specification
• US Code - 28 U.S.C. § 1295 Jurisdiction of the United States Court of Appeals For the Federal Circuit